Table 1.
Included* (%) (n = 1858) | Excluded†† (%) (N = 847) | OR for Exclusion (95% CI)‡‡ | ||
---|---|---|---|---|
Sex | Man | 1111 (60) | 489 (58) | Referent |
Woman | 747 (40) | 358 (42) | 1.09 (.92–1.28) | |
Race | White | 348 (19) | 148 (17) | Referent |
Black | 1510 (81) | 699 (83) | 1.09 (.88–1.34) | |
Age | < 30 | 451 (24) | 183 (22) | Referent |
>/= 30 | 1407 (76) | 664 (78) | 1.16 (.96–1.41) | |
HIV-transmission risk factors§ | IDU | 558 (29) | 335 (40) | Referent |
MSM | 701 (38) | 279 (33) | .65 (.54–.79) | |
All heterosexual | 381 (21) | 149 (18) | .64 (.51–.81) | |
Others | 228 (12) | 84 (10) | .60 (.45–.80) | |
First CD4+ T-cell count | >/= 200 cells/mm3 | 945 (51) | 385 (56) | Referent |
< 200 cells/mm3 | 913 (49) | 297 (44) | .80 (.67–.95) |
Included, first CD4+ T-cell count within 6 months of first reported positive HIV test
Excluded, first CD4+ T-cell count missing (165 persons) or more than 6 months after first reported positive HIV test (682 persons)
OR = odds ratio. The ratio of the odds of being excluded to the odds of being excluded in the referent group; 95% CI, 95% confidence interval. 95% CI's for sex, race, age, and first CD4+ T-cell count are from chi-square tests, and those for the transmission risk categories are from a logistic regression analysis of the transmission risk categories over the outcome. Results that are significant at the 95% level are in bold type.
IDU = injection drug users (including men who have sex with men as well as inject drugs); MSM = men who have sex with men; all heterosexual, both high-risk heterosexual (persons who have heterosexual contact with persons known to be HIV-positive or to have a risk factor for HIV infection) and presumed heterosexual (persons who have heterosexual contact and do not have any other known risk factors); others, persons with blood contact or no identified risk